Citation: Pa. Seligman et al., APPROACH TO THE SERIOUSLY ILL OR TERMINAL CANCER-PATIENT WHO HAS A POOR APPETITE, Seminars in oncology, 25(2), 1998, pp. 33-34
Authors:
CONNELLY KG
MOSS M
PARSONS PE
MOORE EE
MOORE FA
GICLAS PC
SELIGMAN PA
REPINE JE
Citation: Kg. Connelly et al., SERUM FERRITIN AS A PREDICTOR OF THE ACUTE RESPIRATORY-DISTRESS SYNDROME, American journal of respiratory and critical care medicine, 155(1), 1997, pp. 21-25
Citation: Pa. Seligman et al., ASSESSMENT OF A RESPONSE TO IV IRON (FE) IN HEMODIALYSIS-PATIENTS RECEIVING RECOMBINANT ERYTHROPOIETIN (EPO), Journal of the American Society of Nephrology, 7(9), 1996, pp. 1075-1075
Authors:
DIENHART DG
KASLIWAL R
LEAR JL
JOHNSON TK
BLOEDOW DC
HARTMANN C
SELIGMAN PA
MILLER GJ
GLENN SD
MCATEER MJ
THICKMAN D
FEYERABEND A
MADDOCK EN
MADDOCK SW
BUNN PA
Citation: Dg. Dienhart et al., EXTRACORPOREAL IMMUNOADSORPTION OF RADIOLABELED MONOCLONAL-ANTIBODY -A METHOD FOR REDUCTION OF BACKGROUND RADIOACTIVITY AND ITS POTENTIAL ROLE DURING THE RADIOIMMUNOTHERAPY OF CANCER, Antibody immunoconjugates, and radiopharmaceuticals, 7(4), 1994, pp. 225-252
Authors:
SELIGMAN PA
SCHLEICHER RB
SIRIWARDANA G
DOMENICO J
GELFAND EW
Citation: Pa. Seligman et al., EFFECTS OF AGENTS THAT INHIBIT CELLULAR IRON INCORPORATION ON BLADDER-CANCER CELL-PROLIFERATION, Blood, 82(5), 1993, pp. 1608-1617
Authors:
SELIGMAN PA
SIRIWARDANA G
SCHLEICHER R
LUCAS J
GELFAND EW
Citation: Pa. Seligman et al., DEFINITION OF THE IRON (FE) REQUIREMENT DURING G(1)-PHASE OF THE CELL-CYCLE - MEASUREMENTS OF CELL-CYCLE REGULATORY PROTEINS, Blood, 82(10), 1993, pp. 10000432-10000432